Aflac AFL
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Aflac (AFL) Business Model and Operations Summary
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
Key Insights
Aflac (AFL) Core Market Data and Business Metrics
Latest Closing Price
$112.45Market Cap
$61.26 BillionPrice-Earnings Ratio
11.68Total Outstanding Shares
545.82 Million SharesTotal Employees
12,694Dividend
$0.58 Per Share QuarterlyIPO Date
June 14, 1974SIC Description
Accident & Health InsurancePrimary Exchange
New York Stock ExchangeHeadquarters
1932 Wynnton Rd, Columbus, GA, 31999
Historical Stock Splits
If you bought 1 share of AFL before March 19, 2018, you'd have 2 shares today.
Execution Date | Split Amount |
---|---|
March 19, 2018 | 2-for-1 |
Cash Flow Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Net Cash Flow | $2.00 Billion |
Net Cash Flow From Operating Activities | $2.71 Billion |
Net Cash Flow From Financing Activities, Continuing | $-3.49 Billion |
Net Cash Flow From Financing Activities | $-3.49 Billion |
Net Cash Flow From Operating Activities, Continuing | $2.71 Billion |
Net Cash Flow From Investing Activities | $2.78 Billion |
Income Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Income/Loss From Continuing Operations Before Tax | $6.42 Billion |
Other Operating Expenses | $2.01 Billion |
Selling, General, and Administrative Expenses | $3.01 Billion |
Operating Expenses | $5.06 Billion |
Common Stock Dividends | $2 |
Basic Average Shares | $562.49 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Comprehensive Income/Loss Attributable To Parent | $7.99 Billion |
Comprehensive Income/Loss | $7.99 Billion |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Other Comprehensive Income/Loss | $2.54 Billion |
Balance Sheet
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Current Assets | $117.57 Billion |
Equity | $26.10 Billion |
Assets | $117.57 Billion |
Liabilities | $91.47 Billion |
Equity Attributable To Parent | $26.10 Billion |
Equity Attributable To Noncontrolling Interest | $0 |
Historical Dividends
Current dividend: $0.58 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Dec 2, 2024 | Mar 3, 2025 | Feb 19, 2025 | $0.58 | Quarterly |
Oct 30, 2024 | Dec 2, 2024 | Nov 20, 2024 | $0.5 | Quarterly |
Jul 31, 2024 | Sep 2, 2024 | Aug 21, 2024 | $0.5 | Quarterly |
May 1, 2024 | Jun 3, 2024 | May 22, 2024 | $0.5 | Quarterly |
Nov 1, 2023 | Mar 1, 2024 | Feb 21, 2024 | $0.5 | Quarterly |
Nov 1, 2023 | Dec 1, 2023 | Nov 15, 2023 | $0.42 | Quarterly |